A study of bone marrow and peripheral blood samples from patients with myelodysplastic syndrome and chronic myelocytic leukemia identified IRF1 variants lacking exon 2 or both exons 2 and 3 (IRF1Δ2 and IRF1Δ23). This evidence concerns the gene IRF1 and myelodysplastic syndrome.